Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Peripheral retinal neovascularization, Retinal detachment, Falciform retinal fold, and Reduced visual acuity.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Peripheral retinal neovascularization, Retinal detachment, Falciform retinal fold |
No clinical trials have been registered for exudative vitreoretinopathy 8.
31 publications have been identified in PubMed for exudative vitreoretinopathy 8. Research spans Clinical Trial Publication (35%), Case Report / Case Series (16%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 11 | 35% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
Online Mendelian Inheritance in Man
Patient case studies
5 |
16% |
Laboratory research | 5 | 16% |
Disease patterns and progression | 5 | 16% |
Research summaries | 4 | 13% |
New treatment approaches | 1 | 3% |
Ma H (2026). [PMID: 41198107](https://pubmed.ncbi.nlm.nih.gov/41198107/). *Retina (Philadelphia, Pa.)*. [Clinical Trial Publication]
Chauvet-Piat E (2026). [PMID: 41789168](https://pubmed.ncbi.nlm.nih.gov/41789168/). *Frontiers in neurology*. [Basic Science / Preclinical]
Chokchaitanasin R (2026). [PMID: 41022191](https://pubmed.ncbi.nlm.nih.gov/41022191/). *American journal of ophthalmology*. [Gene Therapy / Novel Therapeutics]
Tahoun M (2026). [PMID: 41886127](https://pubmed.ncbi.nlm.nih.gov/41886127/). *International ophthalmology*. [Review / Meta-Analysis]
Grassi P (2026). [PMID: 41994251](https://pubmed.ncbi.nlm.nih.gov/41994251/). *Saudi J Ophthalmol*. [Clinical Trial Publication]
Abu Serhan H (2026). [PMID: 41965841](https://pubmed.ncbi.nlm.nih.gov/41965841/). *Int J Retina Vitreous*. [Review / Meta-Analysis]
Naruse S (2026). [PMID: 42073993](https://pubmed.ncbi.nlm.nih.gov/42073993/). *Int J Mol Sci*. [Epidemiology / Natural History]
Anne RP (2026). [PMID: 42231307](https://pubmed.ncbi.nlm.nih.gov/42231307/). *BMC Pediatr*. [Review / Meta-Analysis]
Okonkwo ON (2025). [PMID: 40953866](https://pubmed.ncbi.nlm.nih.gov/40953866/). *BMJ open*. [Epidemiology / Natural History]
Liu S (2025). [PMID: 41174744](https://pubmed.ncbi.nlm.nih.gov/41174744/). *Orphanet journal of rare diseases*. [Basic Science / Preclinical]